Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin 8% patch treatment in non-freezing cold injury
ISRCTN11180128Phase 4Recruiting
- Sponsor
- Imperial College London
- Start
- Feb 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in neuropathy comparing Qutenza + standard of care with Placebo patch + standard of care (2 arms). Primary endpoint: Pain intensity by visual analogue score. Started Feb 2024; status: recruiting.
02
Drugs
capsaicin
03
Conditions
neuropathy
Beyond the preview
Go deeper on ISRCTN11180128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11180128.